Louisiana State Employees Retirement System’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-7,700
Closed -$200K 1520
2023
Q2
$200K Buy
+7,700
New +$206K ﹤0.01% 1505
2023
Q1
Sell
-6,900
Closed -$204K 1505
2022
Q4
$204K Buy
+6,900
New +$196K 0.01% 1473
2022
Q1
Sell
-7,000
Closed -$251K 1512
2021
Q4
$251K Hold
7,000
0.01% 1478
2021
Q3
$298K Buy
7,000
+500
+8% +$20.6K 0.01% 1449
2021
Q2
$281K Hold
6,500
0.01% 1445
2021
Q1
$265K Hold
6,500
0.01% 1449
2020
Q4
$294K Sell
6,500
-100
-2% -$3.79K 0.01% 1385
2020
Q3
$234K Buy
+6,600
New +$238K 0.01% 1323
2020
Q1
Sell
-4,930
Closed -$256K 1299
2019
Q4
$256K Sell
4,930
-170
-3% -$9.88K 0.01% 1297
2019
Q3
$280K Sell
5,100
-200
-4% -$10.3K 0.01% 1254
2019
Q2
$212K Buy
+5,300
New +$193K 0.01% 1351
2018
Q4
Sell
-6,400
Closed -$270K 1430
2018
Q3
$270K Sell
6,400
-200
-3% -$7.9K 0.01% 1388
2018
Q2
$211K Buy
6,600
+100
+2% +$4.12K 0.01% 1438
2018
Q1
$323K Buy
6,500
+200
+3% +$11.3K 0.01% 1308
2017
Q4
$340K Buy
6,300
+400
+7% +$22.1K 0.02% 1287
2017
Q3
$342K Sell
5,900
-100
-2% -$5.23K 0.02% 1266
2017
Q2
$296K Hold
6,000
0.01% 1291
2017
Q1
$261K Buy
6,000
+100
+2% +$4.77K 0.01% 1330
2016
Q4
$289K Sell
5,900
-600
-9% -$27.7K 0.01% 1300
2016
Q3
$311K Buy
6,500
+200
+3% +$9.88K 0.02% 1262
2016
Q2
$338K Hold
6,300
0.02% 1206
2016
Q1
$282K Sell
6,300
-200
-3% -$8.11K 0.01% 1269
2015
Q4
$248K Buy
6,500
+100
+2% +$3.83K 0.01% 1309
2015
Q3
$204K Sell
6,400
-100
-2% -$3.49K 0.01% 1359
2015
Q2
$215K Hold
6,500
0.01% 1388
2015
Q1
$268K Sell
6,500
-100
-2% -$4.04K 0.01% 1327
2014
Q4
$269K Sell
6,600
-100
-1% -$3.91K 0.01% 1346
2014
Q3
$246K Buy
6,700
+1,200
+22% +$51.9K 0.01% 1350
2014
Q2
$255K Buy
5,500
+300
+6% +$13.3K 0.01% 1365
2014
Q1
$214K Buy
+5,200
New +$193K 0.01% 1401

Other funds holding ANIK

Louisiana State Employees Retirement System's ANIK Position: Q3 2023 in Review

Louisiana State Employees Retirement System sold out of Anika Therapeutics (ANIK) in Q3 2023, closing a stake of 7,700 shares — an estimated $200K sold.

Louisiana State Employees Retirement System first reported a position in ANIK in Q1 2014 and held it in 30 quarters. The position peaked at $342K in Q3 2017. 116 funds tracked by Wall St. Rank hold ANIK as of Q3 2023.

  • Louisiana State Employees Retirement System reported no remaining Anika Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 7,700 Anika Therapeutics shares in Q3 2023, an estimated $200K.
  • Louisiana State Employees Retirement System first reported a position in Anika Therapeutics in Q1 2014 and held it in 30 quarters.
  • Louisiana State Employees Retirement System's Anika Therapeutics position peaked at $342K in Q3 2017.
  • 116 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2023.

Based on Louisiana State Employees Retirement System's 13F filing for Q3 2023, filed 17 Oct 2023.